Anti-tuberculosis medication and the liver: Dangers and recommendations in management

European Respiratory Journal

Volumn 8, Issue 8, 1995, Pages 1384-1388

  Thompson, N P ^a   Caplin, M E ^a   Hamilton, M I ^a   Gillespie, S H ^a   Clarke, S W ^a   Burroughs, A K ^a   McIntyre, N ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Anti tuberculosis therapy; Hepatotoxicity; Isoniazid; Liver

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; PROTIONAMIDE; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

DRUG TOXICITY; HUMAN; LIVER FUNCTION; LIVER TOXICITY; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; HEPATITIS, TOXIC; HUMAN; LIVER; RISK FACTORS; SUPPORT, NON-U.S. GOV'T;

EID: 0029093401     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.95.08081384     Document Type: Review

References (0)